Related Experiment Video
Updated: Jun 22, 2026

10:17
Guidelines and Experience Using Imaging Biomarker Explorer IBEX for Radiomics
Published on: January 8, 2018
13.2K
Development and Validation of an Explainable Radiomics Model to Predict High-Aggressive Prostate Cancer: A
Giulia Nicoletti1,2, Simone Mazzetti3, Giovanni Maimone3
1Department of Electronics and Telecommunications, Polytechnic of Turin, Corso Duca degli Abruzzi, 24, 10129 Turin, Italy.
Cancers
|January 11, 2024
Summary
This study developed a radiomic model using biparametric MRI to differentiate low-aggressive from high-aggressive prostate cancer (PCa). The model achieved promising accuracy, aiding noninvasive PCa classification and management.
Area of Science:
- Radiology and Medical Imaging
- Oncology
- Artificial Intelligence in Medicine
Background:
- Prostate cancer (PCa) aggressiveness, categorized by Grade Group (GG), significantly impacts patient prognosis and mortality.
- Distinguishing between low-aggressive (GG ≤ 2) and high-aggressive (GG ≥ 3) PCa is crucial for effective treatment planning.
Purpose of the Study:
- To develop and externally validate a radiomic model for noninvasive classification of low- vs. high-aggressive prostate cancer.
- To leverage biparametric magnetic resonance imaging (bpMRI) for improved PCa risk stratification.
Main Methods:
- Retrospective analysis of 283 patients across four centers.
- Feature extraction from apparent diffusion coefficient (ADC) maps and T2-weighted (T2w) MRI sequences.
- Development and validation of a Naïve Bayes classifier using cross-validation and external validation sets.
Main Results:
- The radiomic model, based on ten features, achieved an AUC of 0.75 in the construction set and 0.73 in the external validation set.
- Shapley additive explanation (SHAP) values and partial dependence plots (PDP) provided interpretability for the radiomics signature.
- The Naïve Bayes classifier demonstrated robust performance in distinguishing PCa aggressiveness.
Conclusions:
- The developed radiomic model shows potential for noninvasively classifying prostate cancer aggressiveness.
- This approach could assist clinicians in managing men with suspected PCa, potentially improving decision-making.
- Further validation and integration into clinical decision support systems are recommended.
Keywords:
explainable artificial intelligencefeature extractionmagnetic resonance imagingprostate cancerradiomicstumor aggressiveness
